Actinium Pharmaceuticals, Inc Stock Forecast
Weaker technical forecast for Actinium Pharmaceuticals, Inc as stock downgraded to Strong Sell Candidate.
(Updated on Jul 02, 2024)
The Actinium Pharmaceuticals, Inc stock price fell by -3.33% on the last day (Tuesday, 2nd Jul 2024) from $7.20 to $6.96. During the last trading day the stock fluctuated 5.94% from a day low at $6.90 to a day high of $7.31. The price has fallen in 6 of the last 10 days and is down by -12.23% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -54 thousand shares and in total, 180 thousand shares were bought and sold for approximately $1.25 million.
The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -8.06% during the next 3 months and, with a 90% probability hold a price between $5.47 and $8.69 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
ATNM Signals & Forecast
Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Actinium Pharmaceuticals, Inc stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $7.28 and $8.20. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, May 14, 2024, and so far it has fallen -29.63%. Further fall is indicated until a new bottom pivot has been found. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.
Support, Risk & Stop-loss for Actinium Pharmaceuticals, Inc stock
Actinium Pharmaceuticals, Inc finds support from accumulated volume at $6.85 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.410 between high and low, or 5.94%. For the last week the stock has had daily average volatility of 5.17%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (ATNM) For The Upcoming Trading Day Of Wednesday 3rd
For the upcoming trading day on Wednesday, 3rd we expect Actinium Pharmaceuticals, Inc to open at $7.06, and during the day (based on 14 day Average True Range), to move between $6.56 and $7.36, which gives a possible trading interval of +/-$0.403 (+/-5.79%) up or down from last closing price. If Actinium Pharmaceuticals, Inc takes out the full calculated possible swing range there will be an estimated 11.59% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $6.85 (1.58%) than the resistance at $7.31 (5.03%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Actinium Pharmaceuticals, Inc stock A Buy?
Actinium Pharmaceuticals, Inc holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.
Current score: -6.154 Strong Sell Candidate Downgraded
Predicted Opening Price for Actinium Pharmaceuticals, Inc of Wednesday, July 3, 2024
| Fair opening price July 3, 2024 | Current price |
|---|---|
| $7.06 ( 1.39%) | $6.96 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for ATNM
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 7.47 | 7.28% |
| R2 | 7.31 | 5.03% |
| R1 | 7.21 | 3.64% |
| Price | 6.96 | |
| S1 | 6.90 | -0.86% |
| S2 | 6.80 | -2.25% |
| S3 | 6.65 | -4.50% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 8.66 | 24.43% |
| R2 | 7.93 | 13.94% |
| R1 | 7.31 | 5.03% |
| Price | 6.96 | |
| S1 | 6.85 | -1.58% |
| S2 | 6.67 | -4.17% |
| S3 | 6.56 | -5.75% |
FAQ
Click here for our free guide on how to buy Actinium Pharmaceuticals, Inc Stock.
